Edition:
India

Merus NV (MRUS.OQ)

MRUS.OQ on NASDAQ Stock Exchange Global Market

18.31USD
2:29am IST
Change (% chg)

$-0.37 (-1.98%)
Prev Close
$18.68
Open
$18.79
Day's High
$18.85
Day's Low
$18.12
Volume
4,547
Avg. Vol
7,599
52-wk High
$33.48
52-wk Low
$13.33

Chart for

About

Merus NV is a biotechnology company based in the Netherlands. The Company develops differentiating therapeutics for cancer patients. The product programs in the Merus pipeline are based on the Biclonics format. Its products inlcude, among others, MCLA-134 that is designed to bind to a combination of two immunomodulatory targets... (more)

Overall

Beta: --
Market Cap(Mil.): $404.73
Shares Outstanding(Mil.): 19.39
Dividend: --
Yield (%): --

Financials

BRIEF-Merus Provides Clinical Updates For Mcla-117 And Mcla-158 Programs

* MERUS PROVIDES CLINICAL UPDATES FOR MCLA-117 AND MCLA-158 PROGRAMS

04 Jan 2018

BRIEF-Merus Nv Q3 Loss Per Share Eur 0.81

* MERUS ANNOUNCES THIRD QUARTER 2017 FINANCIAL RESULTS AND CLINICAL HIGHLIGHTS

30 Nov 2017

BRIEF-Merus announces Q2 loss per share EUR 1.12

* Merus announces second quarter 2017 financial results and highlights recent progress

20 Sep 2017

BRIEF-U.S. Court of Appeals for Federal Circuit affirms Merus' inequitable conduct claim against Regeneron

* Says U.S. Court of Appeals for Federal Circuit affirms Merus' inequitable conduct claim against regeneron

28 Jul 2017

Earnings vs. Estimates